Opus Genetics, Inc.
Ownership
Ownership Structure
Who owns Opus Genetics, Inc. (IRD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 78.3% of the shares are freely tradable; institutional investors hold 60.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 7.36 | 6,122,718 | +264.2 | 06/30/2026 |
| Caligan Partners LP | 7.30 | 6,077,084 | +0.0 | 06/30/2026 |
| Adage Capital Partners Gp LLC | 7.25 | 6,029,775 | +0.0 | 06/30/2026 |
| BIOS CAPITAL MANAGEMENT, LP | 4.43 | 3,683,429 | +0.0 | 06/30/2026 |
| BlackRock Inc | 3.75 | 3,116,487 | +2,009.4 | 06/30/2026 |
| Balyasny Asset Management LLC | 3.71 | 3,087,866 | +13.6 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.56 | 2,958,683 | +20.8 | 06/30/2026 |
| Boxer Capital Management, LLC | 3.38 | 2,815,000 | +25.1 | 06/30/2026 |
| Trails Edge Capital Partners, LP | 3.30 | 2,743,658 | +448.7 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.80 | 2,328,478 | +4.0 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund | Director | 3,236,171 | 13,268,301 $ | Sep 30, 2026 | direct |
| Gallagher Cam | Director | 2,800,111 | 11,480,455 $ | Sep 8, 2026 | direct |
| Magrath George | Chief Executive Officer | 2,010,636 | 8,243,608 $ | Nov 3, 2026 | direct |
| Yerxa Benjamin R | President | 670,917 | 2,750,760 $ | Oct 23, 2026 | direct |
| Gagnon Robert E. | Chief Financial Officer | 542,375 | 2,223,738 $ | Oct 23, 2026 | direct |
| Schachle Joseph K | Chief Operating Officer | 286,673 | 1,175,359 $ | Oct 23, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | Magrath George | Chief Executive Officer | Sell | 28,258 | 3.90 | 110,184 |
| Oct 23, 2026 | Schachle Joseph K | Chief Operating Officer | Sell | 4,767 | 3.57 | 16,994 |
| Oct 23, 2026 | Yerxa Benjamin R | President | Sell | 25,520 | 3.53 | 90,129 |
| Oct 23, 2026 | Yerxa Benjamin R | President | Sell | 7,669 | 3.55 | 27,236 |
| Oct 23, 2026 | Gagnon Robert E. | Chief Financial Officer | Sell | 14,000 | 3.55 | 49,650 |
| Oct 23, 2026 | Magrath George | Chief Executive Officer | Sell | 9,591 | 3.59 | 34,384 |
| Sep 30, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund | Director | Sell | 556,000 | 4.96 | 2,755,981 |
| Sep 9, 2026 | Magrath George | Chief Executive Officer | Other | 75,541 | 5.97 | 450,980 |
| Sep 9, 2026 | Magrath George | Chief Executive Officer | Other | 392,157 | 1.15 | 450,981 |
| Sep 8, 2026 | Gallagher Cam | Director | Other | 784,314 | 1.15 | 901,961 |
| Sep 3, 2026 | Gagnon Robert E. | Chief Financial Officer | Sell | 28,000 | 4.54 | 127,212 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.